Published in J Med Chem on January 01, 1992
Biosynthesis of cholesterol and other sterols. Chem Rev (2011) 1.30
Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis. Antimicrob Agents Chemother (2004) 1.12
Syntheses and biological activity studies of novel sterol analogs from nitroso Diels-Alder reactions of ergosterol. Org Lett (2009) 0.97
Synthesis and Biological Evaluation of Novel Alkyl-Imidazolyl Carbinols and their Esters: Potent Antimycotics. Sci Pharm (2013) 0.90
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89
Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther (1996) 2.63
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem (1997) 2.28
Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem (1998) 2.12
Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology (2000) 2.12
Enteral tube feeding in the intensive care unit: factors impeding adequate delivery. Crit Care Med (1999) 2.04
Structural basis of inhibitor selectivity in MAP kinases. Structure (1998) 1.89
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials. Pharmacol Ther (1999) 1.80
Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun (1999) 1.80
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol (2000) 1.75
Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum (2000) 1.72
Innervation and blood supply of the antler pedicle of the Red deer. N Z Vet J (1979) 1.56
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther (2001) 1.54
Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J Immunol (2001) 1.47
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev (2001) 1.43
Indole-3-acetic acid catabolism in Zea mays seedlings. Metabolic conversion of oxindole-3-acetic acid to 7-hydroxy-2-oxindole-3-acetic acid 7'-O-beta-D-glucopyranoside. J Biol Chem (1985) 1.39
SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther (2000) 1.37
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem (2000) 1.34
Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Bioorg Med Chem (1997) 1.31
P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1 beta-converting enzyme. J Med Chem (1994) 1.30
Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J Immunol (2000) 1.25
Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem (2001) 1.18
Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts. J Lab Clin Med (1985) 1.15
Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev (1996) 1.13
The bile acid-inducible baiB gene from Eubacterium sp. strain VPI 12708 encodes a bile acid-coenzyme A ligase. J Bacteriol (1992) 1.13
Demonstration, by immunoelectronmicroscopy, of a cell wall antigen in Trichosporon beigelii that cross-reacts with Cryptococcus neoformans capsular polysaccharide. J Infect Dis (1988) 1.13
Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction. Circulation (2001) 1.13
Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils. J Infect Dis (1986) 1.10
Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc Natl Acad Sci U S A (2000) 1.08
An air curtain incubator for use in an intensive-care nursery. J Pediatr (1971) 1.06
Studies on the active site of succinyl-CoA:tetrahydrodipicolinate N-succinyltransferase. Characterization using analogs of tetrahydrodipicolinate. J Biol Chem (1986) 1.06
Culturability as an indicator of succession in microbial communities. Microb Ecol (2001) 1.05
Current activity guidelines for CABG patients are too restrictive: comparison of the forces exerted on the median sternotomy during a cough vs. lifting activities combined with valsalva maneuver. Thorac Cardiovasc Surg (2008) 1.05
Peripherally restricted opioid agonists as novel analgesic agents. Curr Pharm Des (2004) 1.05
A systematic review of patient information leaflets for hypertension. J Hum Hypertens (2000) 1.03
Patterns of death, complication, and error in the management of motor vehicle accident victims: implications for a regional system of trauma care. J Trauma (1983) 1.01
Inhibitors of serine/threonine kinases. Curr Opin Biotechnol (1995) 1.00
Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor. J Med Chem (1993) 1.00
Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library. Bioorg Med Chem Lett (1998) 0.97
Infusion protocol improves delivery of enteral tube feeding in the critical care unit. JPEN J Parenter Enteral Nutr (1999) 0.96
Measuring the incremental cost of clinical cancer research. J Clin Oncol (2001) 0.95
3-Aminopropylphosphinic acid--a potent, selective GABAB receptor agonist in the guinea-pig ileum and rat anococcygeus muscle. Br J Pharmacol (1989) 0.95
Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats. J Pharmacol Exp Ther (1987) 0.94
Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis. Invest Ophthalmol Vis Sci (1992) 0.94
Synthesis of beta,gamma-unsaturated amino acids. J Org Chem (1977) 0.93
Immediate cranial nerve paralysis during removal of a mandibular third molar. Oral Surg Oral Med Oral Pathol (1987) 0.92
Mycobacterium paratuberculosis monoassociated nude mice as a paratuberculosis model. Vet Pathol (1991) 0.92
Inhibition of mature IL-1 beta production in murine macrophages and a murine model of inflammation by WIN 67694, an inhibitor of IL-1 beta converting enzyme. J Immunol (1995) 0.91
The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist. Proc Natl Acad Sci U S A (1994) 0.91
Effect of tirilazad mesylate (U74006F) on eicosanoid and tumor necrosis factor generation in healthy and endotoxemic neonatal calves. Circ Shock (1993) 0.89
The copper sites of dopamine beta-hydroxylase: an X-ray absorption spectroscopic study. Biochemistry (1988) 0.89
Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine beta-hydroxylase. J Med Chem (1986) 0.89
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study. HIV Med (2013) 0.88
Effect of metabolic inhibitors on ATP and citrate content in PC3 prostate cancer cells. Prostate (2007) 0.87
1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency. J Med Chem (1996) 0.87
Cerebrospinal fluid leakage complicating orbital exenteration. Arch Ophthalmol (1989) 0.87
A substrate combinatorial array for caspases. Bioorg Med Chem Lett (1999) 0.85
Preparation and evaluation of peptidic aspartyl hemiacetals as reversible inhibitors of interleukin-1 beta converting enzyme (ICE). Int J Pept Protein Res (1994) 0.84
Mechanism-based inactivation of dopamine beta-hydroxylase by p-cresol and related alkylphenols. Biochemistry (1987) 0.84
Design and synthesis of 14 alpha-methyl-15-aza-D-homosterols as novel antimycotics. J Med Chem (1990) 0.84
Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding site. J Med Chem (1987) 0.84
The pattern of cadmium in the environment of five Minnesota cities. Environ Geochem Health (1991) 0.83
Inhibitors of dopamine beta-hydroxylase. 3. Some 1-(pyridylmethyl)imidazole-2-thiones. J Med Chem (1987) 0.83
Treatment of experimental gram-negative and gram-positive bacterial sepsis with the hematoregulatory peptide SK&F 107647. J Infect Dis (1996) 0.82
Multisubstrate inhibitors of dopamine beta-hydroxylase. 1. Some 1-phenyl and 1-phenyl-bridged derivatives of imidazole-2-thione. J Med Chem (1986) 0.82
Differential effects of manoalide on secreted and intracellular phospholipases. Biochem Pharmacol (1987) 0.82
Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production. Drugs Exp Clin Res (1993) 0.82
Relationship between physical properties and sensory attributes of carbonated beverages. J Food Sci (2007) 0.82
Sequence similarity between dopamine beta-hydroxylase and peptide alpha-amidating enzyme: evidence for a conserved catalytic domain. FEBS Lett (1989) 0.81
ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme. J Med Chem (1996) 0.81
Detection of transforming growth factor-alpha messenger RNA and protein in human corneal epithelial cells. Invest Ophthalmol Vis Sci (1992) 0.81
A method for detecting the time course of correlation between single-unit activity and EMG during a behavioral task. J Neurosci Methods (1995) 0.80
SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock. J Pharmacol Exp Ther (1995) 0.80
The use of obstetrical procedures in the care of low-risk women. Women Health (1983) 0.80
Hydrodynamic properties of the purified glutamate-binding protein subunit of the N-methyl-D-aspartate receptor. J Biol Chem (1991) 0.80
Synthesis and evaluation of (+) and (-)-2,2-difluorocitrate as inhibitors of rat-liver ATP-citrate lyase and porcine-heart aconitase. Eur J Biochem (1991) 0.80
Selective inhibition of 5-lipoxygenase attenuates glomerulonephritis in the rat. Kidney Int (1994) 0.80
Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase. Biochemistry (1986) 0.79
Identification of unique truncated KC/GRO beta chemokines with potent hematopoietic and anti-infective activities. J Immunol (2000) 0.79
Developmental changes of beta-adrenergic receptor-linked adenylate cyclase of rat liver. Am J Physiol (1985) 0.79
Mechanism and inhibition of delta 24-sterol methyltransferase from Candida albicans and Candida tropicalis. Biochemistry (1989) 0.79
Phenoxypyrimidine inhibitors of p38alpha kinase: synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles. Bioorg Med Chem Lett (2001) 0.79
Suspected transmission of Mycobacterium bovis between alpacas. Vet Rec (2009) 0.78
Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor. J Med Chem (1997) 0.78
Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D. Bioorg Med Chem Lett (1998) 0.78
Efficacy of the hematoregulatory peptide SK&F 107647 in experimental systemic Candida albicans infections in normal and immunosuppressed mice. Immunopharmacology (1994) 0.78
Investigating the moisture sorption behavior of amorphous sucrose using a dynamic humidity generating instrument. J Food Sci (2008) 0.77
Isolation and chemical analyses of nonfermented fiber fractions of oat hulls and cottonseed hulls. J Anim Sci (1991) 0.77
Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells. J Biol Chem (1991) 0.77
Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats. J Pharmacol Exp Ther (1988) 0.77
Functional properties of butter oil made from bovine milk with experimentally altered fat composition. J Dairy Sci (2007) 0.77
ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitors. J Med Chem (1992) 0.77
Small molecule antagonists of the bradykinin B1 receptor. Immunopharmacology (1999) 0.76
Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma. J Pharmacol Exp Ther (1995) 0.76